Wyndham Hotels & Resorts delivered a cleaner beat than the year-over-year comparison suggests. Adjusted EPS of $1.43 topped the $1.32 consensus and the $1.34 Earnings Whisper number by 6.7%, even though earnings fell 2.1% from a year ago. Revenue rose 7.3% to $410.0 million, essentially in line with expectations at a 0.2% shortfall. The headline decline is mostly an accounting-timing artifact. Marketing fund revenues exceeded expenses by only $1 million this quarter versus $18 million a year earlier. Stripping out that swing, comparable adjusted EPS rose about 9% and comparable adjusted EBITDA grew 5%. The more important development is that U.S. RevPAR has decisively turned, and that drove Wyndham's third consecutive guidance raise.

The U.S. trajectory is the core of the story. Domestic RevPAR moved from roughly -6% in the fourth quarter of 2025 to flat in the first quarter, +2% in the second and +6% in the third. Occupancy and ADR each contributed nearly 300 basis points, and growth was broad-based across chain scales and regions. Comparable EBITDA growth has followed the same path, accelerating from -1% in Q1 to +3% in Q2 and +5% now. Royalties and franchise fees grew 6%, back in line with the company's long-term algorithm. Global RevPAR rose 2% in constant currency, about four points better than the prior quarter. International remained a drag at -3%, though that was an improvement from -6%.

The quality of the beat still deserves some scrutiny. GAAP net income fell 6% to $99 million. General and administrative expense rose to $36 million from $26 million, and corporate EBITDA losses widened to $22 million from $15 million, partly reflecting the lapping of one-time cost cuts made in 2025. Share count reduction also did meaningful work: diluted shares fell to 74.3 million from 76.9 million. That made per-share growth outpace the underlying operating gains.

The guidance raise was substantive. Adjusted EPS guidance moved to $4.84-$4.92 from $4.71-$4.83. Adjusted EBITDA guidance moved to $740-$745 million from $735-$745 million, and global RevPAR guidance to +0.5%-1.0%. The outlook assumes fourth-quarter domestic RevPAR merely holds at third-quarter levels. Management's commentary arguably supports that as a reasonable, not stretched, base:

• Booking pace is the strongest since COVID.
• More than 7% more business is on the books for the next 60 days.
• Infrastructure-related bookings accelerated to +16% from +12%.

The central tension is that revenue per room is improving while the room-growth engine is sputtering. Net room growth guidance was narrowed to about 4% from 4%-4.5%. U.S. rooms declined 1% year over year, with economy rooms down 3%, and year-to-date global deletions jumped 44%. Management attributed the slowdown to:

• higher terminations of substandard hotels;
• a more than 30% drop in economy and midscale buy-sell transactions;
• rising rates that are widening bid-ask spreads and slowing conversions.

Ancillary revenue guidance was also trimmed to low double digits from low-to-mid teens. Other risks remain:

• China RevPAR deteriorated to -10% from -5%.
• The Middle East is still down 13%.
• U.S. royalty rates slipped slightly.
• The remaining Revo rooms are terminating in the fourth quarter.

There are offsets. The pipeline reached a record of roughly 264,000 rooms, with a roughly 30% FeePAR premium to the existing system. Retaining 5,000-6,000 Revo rooms could add upside in 2027. The Sports Illustrated Resorts launch with Travel + Leisure and expanding agentic-AI booking distribution are smaller but real catalysts.

Capital return reinforces the setup. Third-quarter buybacks rose 30% to $91 million, the board added $400 million to the authorization, and net leverage of 3.6x sits mid-range of the 3x-4x target. Investor sentiment remains negative but improved meaningfully, rising from -0.36 at the prior report to -0.13. That suggests skepticism is fading, though it has not flipped to optimism. Shares are up 5.1% since the open following the July report at $78.36, sitting almost exactly on the 200-day moving average of $78.07. The stock has recovered to a neutral technical position rather than breaking out, though the AVWAP trend reading is positive.

The bottom line is that Wyndham produced a credible demand inflection and a well-supported guidance raise, and comparable growth is accelerating beneath a misleading year-over-year EPS decline. Bulls now have a domestic RevPAR recovery that skeptics were not positioned for. Bears retain legitimate ammunition in shrinking U.S. room counts, softer ancillary growth and a weakening China. Whether the stock can move decisively beyond its 200-day average likely depends on evidence that unit growth stabilizes alongside pricing.